Compass Therapeutics, Inc. Share Price
Stocks
CMPX
US20454B1044
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Nasdaq
01:30:00 12/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 2.000 USD | -2.44% |
|
-15.97% | -62.76% |
| Market Cap | 37Cr 32Cr 30Cr 27Cr 51Cr 3.53TCr 51Cr 357.71Cr 137.56Cr 1.79TCr 138.65Cr 135.61Cr 5.67TCr | P/E 2026 * |
-4.09x | P/E 2027 * | -3.71x |
|---|---|---|---|---|---|
| Enterprise Value | 22Cr 19Cr 18Cr 16Cr 30Cr 2.09TCr 31Cr 212.37Cr 82Cr 1.07TCr 82Cr 81Cr 3.37TCr | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 10.5x |
| Free-Float |
87.55% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| CMPX | Delayed | |
CBOE
| CMPX | Real-time |
Last Transcript : Compass Therapeutics, Inc.
| 1 day | -2.44% | ||
| 1 week | -15.97% | ||
| Current month | -16.32% | ||
| 1 month | -9.09% | ||
| 3 months | -0.50% | ||
| 6 months | -64.22% | ||
| Current year | -62.76% |
| 1 week | 1.96 |  | 2.32 |
| 1 month | 1.96 | | 2.55 |
| Current year | 1.61 | | 6.88 |
| 1 year | 1.61 | | 6.88 |
| 3 years | 0.76 | | 6.88 |
| 5 years | 0.76 | | 6.88 |
| 10 years | 0.76 | | 11 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Schuetz
CEO | Chief Executive Officer | 65 | 28/05/2024 |
Barry Shin
DFI | Director of Finance/CFO | 54 | 09/12/2024 |
Bing Gong
CTO | Chief Tech/Sci/R&D Officer | 50 | 01/01/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Schuetz
BRD | Director/Board Member | 65 | 01/01/2014 |
Phil Ferneau
BRD | Director/Board Member | 64 | 01/01/2015 |
Carl Gordon
CHM | Chairman | 61 | 01/01/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 29/04/26 | Buy | Controller/Auditor | 15,000 | 0.0083% | ||
| 29/04/26 | Buy | General Counsel | 25,000 | 0.0139% | ||
| 29/04/26 | Free | Controller/Auditor | 15,000 | 0.0083% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.44% | -15.97% | -43.34% | -11.50% | 37Cr | |
| -2.11% | -3.44% | +41.04% | +98.48% | 6.82TCr | |
| -0.23% | -6.42% | +30.19% | +76.15% | 6.22TCr | |
| +1.67% | +2.47% | -11.23% | +388.34% | 2.78TCr | |
| -1.05% | -7.30% | +25.00% | +12.31% | 2.49TCr | |
| +0.34% | -6.78% | -7.27% | -17.99% | 2.42TCr | |
| +0.43% | -4.78% | +18.26% | -20.61% | 1.94TCr | |
| -3.03% | -5.19% | +192.88% | +340.13% | 1.73TCr | |
| -1.94% | -6.36% | -7.05% | +516.16% | 1.45TCr | |
| -2.28% | -4.90% | +43.64% | +155.21% | 1.42TCr | |
| Average | -1.06% | -4.91% | +28.21% | +153.67% | 2.73TCr | |
| Weighted average by Cap. | -0.86% | -3.82% | +32.97% | +136.50% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 2.24Cr 1.93Cr 1.83Cr 1.66Cr 3.11Cr 213.94Cr 3.12Cr 22Cr 8.34Cr 108.84Cr 8.41Cr 8.23Cr 343.93Cr |
| Net income | -9.4Cr -8.1Cr -7.67Cr -6.95Cr -13Cr -898.44Cr -13Cr -91Cr -35Cr -457.09Cr -35Cr -35Cr -1.44TCr | -11Cr -9.46Cr -8.96Cr -8.12Cr -15Cr -1.05TCr -15Cr -106.42Cr -41Cr -533.81Cr -41Cr -40Cr -1.69TCr |
| Net Debt | -15Cr -13Cr -12Cr -11Cr -21Cr -1.43TCr -21Cr -145.34Cr -56Cr -729.06Cr -56Cr -55Cr -2.3TCr | -13Cr -11Cr -11Cr -9.83Cr -18Cr -1.27TCr -19Cr -128.87Cr -50Cr -646.44Cr -50Cr -49Cr -2.04TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/26/12 | $2.000 | -2.44% | 48,26,114 |
| 10/26/10 | $2.050 | -5.96% | 25,41,061 |
| 09/26/09 | $2.180 | -1.36% | 26,14,911 |
| 08/26/08 | $2.210 | -7.14% | 24,28,040 |
| 04/26/04 | $2.380 | +0.42% | 25,48,324 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CMPX Stock
Select your edition
All financial news and data tailored to specific country editions
